TrueTicker

NIFTY 500 › Chemicals

Chemicals · NIFTY 500

PCBL Chemical Ltd.

PCBL on NSE · 19 Nov 2026

NIFTY 500

271.55 ▼ -0.02 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Filings

41 filings of PCBL since December 2024; the newest 40 below.

credit rating 12, transcript 8, presentation 7, board outcome 7, dividend 4, results 2

FiledTypeSubject
06 Nov 2026transcript
Guidance, Results
PCBL Chemical Limited has informed the Exchange about Q2 FY 27 Results Conference Call Transcript
AI summary

PCBL filed the transcript of its Q2 FY27 and H1 FY27 results conference call held on 2 November 2026, covering the quarter and half year ended 30 September 2026.

Management (MD Nilesh Koul) said consolidated revenue grew 14% year-on-year to INR 2,474 crores, EBITDA grew 12% to INR 310 crores and profit after tax grew 20% to INR 74 crores in the quarter.

Carbon black sales volume was 134,180 tonnes (92,843 tonnes domestic, 41,337 tonnes export); Aquapharm reported revenue of INR 433 crores and EBITDA of INR 42 crores.

Management reiterated guidance of double-digit growth in average EBITDA per tonne over FY26 levels and double-digit revenue growth for Aquapharm in FY27.

Management said customer destocking and geopolitical disruption weighed on volumes, and that it remains constructive on the strong second half while the timing of recovery depends on market conditions.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
02 Nov 2026presentation
Results
PCBL Chemical Limited has informed the Exchange about Presentation
AI summary

PCBL Chemical Limited filed its Q2 FY27 Investor Update/Presentation dated 2 November 2026, also posted on the company website.

Presentation describes PCBL as a global specialty chemical player in carbon black, specialty and solutions, and advanced battery materials, with India's largest carbon black capacity and a total installed capacity of 900 KTPA carbon black.

Q2 FY27 consolidated financial snapshot: revenue from operations Rs. 2,474 Cr, EBITDA Rs. 310 Cr, PAT Rs. 74 Cr.

Specialty & Solutions (Aquapharm Chemical) segment: revenue Rs. 433 Cr (+14% YoY), EBITDA Rs. 42 Cr (+12% YoY), and a further +20% YoY metric shown on the snapshot page.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
02 Nov 2026board outcome
Legal, Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
AI summary

PCBL Chemical Limited filed the outcome of its board meeting held on 2 November 2026, which ran from 12:00 noon to 13:10 P.M.

The board approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, enclosed with the Limited Review Reports of the statutory auditors.

The filing also encloses the security cover certificate under Regulation 54 for the secured non-convertible debentures, showing a security cover of 4.37 times against a requirement of not less than 1.5 times under the Debenture Trust Deed.

The debentures are secured by a first ranking exclusive pledge over shares of Aquapharm Chemical Limited, with the pledged investment valued at Rs 2,280.00 crores as at 30 September 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
05 Aug 2026transcript
Capex, Guidance, Management change, Results
PCBL Chemical Limited has informed the Exchange about Transcript
AI summary

PCBL filed the transcript of its Q1 FY27 earnings conference call held on 29 July 2026, for the quarter ended 30 June 2026.

Management said consolidated revenue from operations grew 17% year-on-year to INR2,474 crores, consolidated EBITDA grew 23% to INR400 crores and profit after tax grew 65% to INR155 crores.

Management said carbon black sales volume was steady at 153,513 metric tons, with domestic volume up 15% to 102,985 tons, and that a 20,000 MTPA specialty black line in Mundra was commissioned in Q1 FY27, taking total carbon black capacity to 900,000 MTPA.

Management said some customers have adopted a more cautious procurement approach, likely temporarily affecting Q2 volumes, and it remains constructive on the second half of FY27.

Management said Aquapharm reported sales volume of 22,985 metric tons, revenue of INR394 crores and EBITDA of INR47 crores, and that Rohit Narang has joined as CEO of Aquapharm Chemicals.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Jul 2026presentation
Capex, Dividend / buy-back, Results
PCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical Limited filed its Investor Update / Q1 FY27 investor presentation on 29 July 2026.

Consolidated Q1FY27 revenue from operations was Rs. 2,474 Cr, EBITDA Rs. 400 Cr and PAT Rs. 155 Cr, as shown on the financial snapshot slide.

Specialty & Solutions (Aquapharm Chemical) revenue was Rs. 394 Cr, up 17% YoY, and EBITDA was Rs. 47 Cr, up 65% YoY; the slide shows +23% YoY for the segment's other metric.

The Board has declared an interim dividend of Rs. 4.5 per equity share.

The presentation describes the company's footprint of 900 KTPA carbon black capacity and 167 KTPA specialty & solutions capacity.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Jul 2026dividend
Dividend / buy-back, Rating, Results
PCBL Chemical Limited has informed the Exchange that Board of Directors at its meeting held on July 29, 2026, declared Interim Dividend of Rs. 4.50 per equity share.
AI summary

Outcome of the Board Meeting held on 29 July 2026 (meeting ran 12:30 PM to 2:15 PM) was filed for PCBL Chemical Limited.

The Board approved unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, with limited review reports from the statutory auditors, and the security cover certificate under Regulation 54.

The Board declared an interim dividend of 450% (Rs 4.50 per equity share of Re 1 each) for the financial year ending 31 March 2027, with 4 August 2026 fixed as the record date.

The security cover certificate shows a security cover of 4.47 times against the 1.5 times required under the Debenture Trust Deed, on debentures of Rs 509.92 crore (including Rs 19.92 crore of accrued interest).

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Jul 2026board outcome
Dividend / buy-back, Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
AI summary

Board of PCBL Chemical Limited met on 29 July 2026 (12:30 PM to 2:15 PM) and approved unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, with limited review reports from statutory auditors.

Board declared an interim dividend of 450% (Rs 4.50 per equity share of Re 1 each) for the financial year ending 31 March 2027, with 4 August 2026 fixed as the record date.

Security cover certificate under Regulation 54 was enclosed: security cover for debentures secured by pledge of Aquapharm Chemical Limited shares is 4.47 times, against a requirement of not less than 1.5 times under the Debenture Trust Deed.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
07 Jul 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating update received from CARE Ratings Limited (letter dated 6 July 2026, reference CARE/KRO/RL/2026-27/1121).

Long term bank facilities of Rs. 750.00 crores: CARE AA (Negative), reaffirmed.

Long term / short term bank facilities of Rs. 3,815.00 crores: CARE AA (Negative) / CARE A1+, reaffirmed.

Short term bank facilities of Rs. 100.00 crores: CARE A1+, reaffirmed.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
07 May 2026transcript
Capex, Guidance, Results
PCBL Chemical Limited has informed the Exchange about Q4 FY 26 Earnings Conference Call Transcript
AI summary

PCBL filed the transcript of its Q4 FY26 earnings conference call held on 30 April 2026, covering the quarter and year ended 31 March 2026.

Management said Q4 consolidated carbon black revenue from operations was INR2,066 crores and consolidated EBITDA was INR248 crores; sales volume rose 8% YoY to 1,61,865 MT.

For FY26, consolidated revenue from operations was INR8,189 crores (FY25: INR8,404 crores) and consolidated EBITDA was INR1,081 crores (FY25: INR1,384 crores).

Management said net borrowings fell by INR454 crores to INR4,536 crores during FY26 while INR750 crores of capex was funded, and it expects double-digit EBITDA growth as the environment normalises.

Management said the West Asia conflict raised raw material, freight and packing costs, with full cost pass-through expected to reflect in numbers by Q2 FY27.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Apr 2026board outcome
Legal, Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
AI summary

PCBL Chemical Limited's board met on 30 April 2026 (12 noon to 1:46 p.m.) and approved the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026.

The filing encloses the statement of assets and liabilities, cash flow statement, auditors' reports with unmodified opinion, and a Regulation 54 security cover statement.

Statutory auditor SR Batliboi & Co. LLP issued unmodified audit reports on the results, as declared by the CFO, Raj Kumar.

The security cover statement shows an exclusive security cover ratio of 4.58 times against a required minimum of 1.5 times for debentures secured by pledged shares of Aquapharm Chemical Limited, with a debt amount of Rs. 498.07 crores.

The results themselves (revenue, profit figures) are not stated in the first pages provided.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited (erstwhile PCBL Limited) filed a credit rating update received from ICRA Limited dated 12 February 2026.

ICRA reaffirmed [ICRA]AA (Negative) on Rs. 700.00 crore Non-Convertible Debentures, with Rating Action "Reaffirmed".

ICRA reaffirmed [ICRA]A1+ on Rs. 500.00 crore Commercial Paper.

ICRA reaffirmed [ICRA]AA (Negative) on Long Term Fund Based facilities: Working Capital Term Loan Rs. 480.00 crore, Term Loan Rs. 583.10 crore, and Unallocated Rs. 136.90 crore.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
09 Feb 2026transcript
Capex, Guidance, Management change, Results
PCBL Chemical Limited has informed the Exchange about Transcript
AI summary

PCBL filed the transcript of its Q3 FY26 earnings conference call, held on 3 February 2026, for the quarter and nine months ended 31 December 2025.

Management reported Q3 consolidated revenue from operations of Rs. 1,846 crores and consolidated EBITDA of Rs. 231 crores, with a one-time labour code provision of Rs. 21 crores; carbon black sales volume was 141,271 metric tons, down 2% YoY.

For nine months FY26, consolidated revenue from operations was Rs. 6,124 crores against Rs. 6,317 crores, and consolidated EBITDA was Rs. 834 crores against Rs. 1,067 crores.

Management said Q3 was affected by geopolitical developments and volatile markets, and that Aquapharm's CEO Suresh Kalra resigned, with interim leadership in place.

Management targets cumulative cost savings of Rs. 200 crores over the next two years and expects the India-US trade deal (18% tariff) and India-EU FTA to help exports.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
03 Feb 2026board outcome
Legal, Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AI summary

The Board of PCBL Chemical Limited met on 3 February 2026 and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, along with the statutory auditors' limited review reports.

The security cover certificate under Regulation 54 of the SEBI Listing Regulations was also enclosed.

The Board authorised Nilesh Koul (Managing Director), Kaushik Mukherjee (Company Secretary and Chief Legal Officer) and Raj Kumar Gupta (Chief Financial Officer) to determine materiality of events under the Company's Material Events policy.

The meeting ran from 11:30 A.M. to 1:30 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 10 January 2026 for its Rs. 600 crore Non-Convertible Debentures.

Crisil Ratings Limited, in its letter dated 9 January 2026, reviewed the rating on the NCDs.

Crisil reaffirmed the rating at Crisil AA with a Negative outlook on the Rs. 600.00 crore NCDs.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 10 January 2026 for its Rs. 100 crore Non-Convertible Debentures.

Crisil Ratings Limited, in its letter dated 9 January 2026, reviewed the rating on the NCDs.

Crisil reaffirmed the rating on the Rs. 100.00 crore NCDs at Crisil AA with a Negative outlook.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 10 January 2026 to NSE and BSE.

Crisil Ratings Limited, in its letter dated 9 January 2026, reviewed the rating on the company's Rs. 550 crore Commercial Paper.

Crisil reaffirmed the rating on the Rs. 550.00 crore Commercial Paper at Crisil A1+.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2026credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 10 January 2026 for its bank facilities.

Crisil Ratings Limited, in its letter dated 9 January 2026, reviewed and reaffirmed ratings on long-term bank loan facilities totalling Rs. 800.00 crores.

The facilities comprise term loans of Rs. 350.00 crores, Rs. 150.00 crores and Rs. 300.00 crores, each rated Crisil AA/Negative.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
24 Oct 2025transcript
Capex, Guidance, Legal, Results
PCBL Chemical Limited has informed the Exchange about Transcript
AI summary

PCBL Chemical filed the transcript of its Q2 FY26 earnings conference call held on 17 October 2025, for the quarter and half year ended 30 September 2025.

Management said Q2 consolidated carbon black sales volume rose 5% QoQ to 1,61,728 metric tons, with capacity utilization above 99%; consolidated revenue from operations was Rs. 2,164 crore, EBITDA Rs. 278 crore, PBT Rs. 78 crore and PAT Rs. 62 crore.

For H1 FY26, consolidated revenue from operations was Rs. 4,278 crore (vs Rs. 4,307 crore in H1 FY25) and consolidated EBITDA was Rs. 603 crore (vs Rs. 738 crore).

Management said margins were hit by continued pricing pressure and US tariffs, and expects profitability to recover in coming quarters.

Aquapharm Q2 FY26 revenue was Rs. 395 crore (up 9%) with EBITDA of Rs. 48 crore; management expects visible EBITDA improvement from Q3 onwards.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Oct 2025presentation
Capex, Guidance, Results
PCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical filed its Investor Update for Q2 FY26 (quarter ended 30 September 2025).

Carbon black sales volume rose 5% QoQ to 1,61,728 MT in Q2FY26 from 1,54,093 MT in Q1FY26; specialty black sales volume rose 9% QoQ to 17,505 MT.

Consolidated revenue from operations was Rs. 2,164 Cr and consolidated EBITDA Rs. 278 Cr; PBT was Rs. 78 Cr.

Aquapharm Chemical reported revenue from operations of Rs. 395 Cr and EBITDA of Rs. 48 Cr in Q2FY26.

Management said working capital cycle improved by 12 days in H1 FY26, releasing about Rs. 240 crore of cash, and gross debt fell by over Rs. 300 crore since March 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Oct 2025dividend
Dividend / buy-back, Results
PCBL Chemical Limited has informed the Exchange that Board of Directors at its meeting held on October 17, 2025, declared Interim Dividend of Rs. 6.00 per equity share.
AI summary

Board of PCBL Chemical Limited met on 17 October 2025 and approved unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025, with limited review reports.

Board declared an interim dividend of 600%, i.e. Rs. 6.00 per equity share of Re. 1 each, for the financial year ending 31 March 2026.

Record date for the interim dividend is Monday, 27 October 2025.

Security cover certificate under Regulation 54 is enclosed, showing a security cover of 1.88 times against a requirement of not less than 1.5 times under the Debenture Trust Deed.

The board meeting commenced at 12:00 noon and concluded at 1:55 PM.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Oct 2025board outcome
Dividend / buy-back, Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AI summary

PCBL Chemical Limited filed the outcome of its board meeting held on 17 October 2025, which approved unaudited standalone and consolidated financial results with limited review reports for the quarter and half year ended 30 September 2025.

The board declared an interim dividend of Rs. 6.00 per equity share of Re. 1 each (600%) for the financial year ending 31 March 2026, with 27 October 2025 fixed as the record date.

The filing also encloses the security cover certificate under Regulation 54; the security cover is shown as 1.88 times against a requirement of not less than 1.5 times under the Debenture Trust Deed.

The board meeting commenced at 12:00 noon and concluded at 1:55 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Sep 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating disclosure for bank facilities of PCBL(TN) Limited, its wholly owned subsidiary.

CARE Ratings Limited reaffirmed long-term bank facilities of Rs. 1,353.80 crore at CARE AA-; Stable.

CARE Ratings Limited reaffirmed short-term bank facilities of Rs. 825.00 crore at CARE A1+.

Total rated bank facilities amount to Rs. 2,178.80 crore; the rating letter is dated 9 September 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Sep 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 10 September 2025 for bank facilities, referring to CARE Ratings letter dated 9 September 2025.

CARE Ratings reaffirmed long-term bank facilities of Rs. 1,325.00 crore at CARE AA; Stable.

CARE Ratings reaffirmed long-term/short-term bank facilities of Rs. 3,815.00 crore at CARE AA; Stable / CARE A1+.

CARE Ratings reaffirmed short-term bank facilities of Rs. 100.00 crore at CARE A1+, for a total of Rs. 5,240.00 crore.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Sep 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating disclosure dated 10 September 2025, citing a CARE Ratings letter dated 9 September 2025.

CARE Ratings reaffirmed the rating on PCBL's Non-Convertible Debentures (NCD) of Rs. 700.00 crores at CARE AA; Stable.

Total rated amount is Rs. 700.00 crores.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
07 Sep 2025presentation
Capex, Guidance
PCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical Limited filed an intimation under Regulation 30 of the SEBI LODR Regulations, 2015, enclosing its investor presentation (RPSG Investor Day, September 2025) to be made at an Investors' Conference on 8 September 2025.

The presentation describes the RPSG Group as a diversified conglomerate with group turnover of ₹42,100 Cr (~US$5 Bn), asset base of ₹67,700 Cr (US$8 Bn) and EBITDA of ₹7,900 Cr (~US$930 Mn) for FY25.

The presentation states PCBL has 790 KT total carbon black capacity across 5 plants and 142 KT specialty capacity across 4 plants, and aims for 1 million MTPA carbon black capacity by FY28.

The presentation states the Group aims for 3.2 GW renewable energy capacity by FY29 and 10 GW by FY32.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Jul 2025transcript
Capex, Guidance, Results
PCBL Chemical Limited has informed the Exchange about Transcript
AI summary

PCBL filed the transcript of its Q1 FY26 earnings conference call, held on 23 July 2025, for the quarter ended 30 June 2025.

Management reported consolidated revenue from operations of INR 2,114 crores, consolidated EBITDA of INR 325 crores (up around 2.5% QoQ), PBT of INR 120 crores and PAT of INR 94 crores.

Carbon black sales volume was 1,54,093 MT (up 2.6% QoQ) at over 97% capacity utilisation; Aquapharm sales volume was 26,523 MT (up over 9% YoY) with revenue of INR 382 crores and EBITDA of INR 50 crores.

Management said it expects Aquapharm to deliver strong growth in FY26 versus FY25, and that the Tamil Nadu brownfield expansion's second phase (additional 60,000 MTPA) will be commissioned by end of FY26.

Management declined to give a full-year EBITDA per kg guidance for carbon black, citing internal efficiency initiatives and uncertainty around tariffs and pricing negotiations.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 Jul 2025presentation
Capex, Results
PCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical filed its Investor Update / Q1 FY26 investor presentation dated 23 July 2025.

Consolidated revenue from operations for Q1FY26 stood at Rs. 2,114 Cr, consolidated EBITDA at Rs. 325 Cr and PBT at Rs. 120 Cr.

Consolidated EBITDA per MT for Carbon Black was Rs. 17,791 in Q1FY26; carbon black sales volume rose 2.6% QoQ to 1,54,093 MT.

Aquapharm Chemical reported Q1FY26 revenue from operations of Rs. 382 Cr and EBITDA of Rs. 50 Cr on sales volume of 26,523 MT.

Land acquisition of 116 acres is underway in Andhra Pradesh for a greenfield carbon black unit; Aquapharm commissioned an 11,500 MTPA polymer capacity expansion at Mahad.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 Jul 2025board outcome
Results
PCBL Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
AI summary

The Board of PCBL Chemical Limited met on 23 July 2025 and approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025, along with the Limited Review Reports of the Statutory Auditors.

The security cover certificate under Regulation 54 of the SEBI Listing Regulations was also enclosed.

The financial results extract will be published in newspapers, and the full format is available on the NSE, BSE and company websites.

The Board meeting commenced at 12:00 noon and concluded at 1:55 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
05 May 2025transcript
Capex, Guidance, Results
PCBL Chemical Limited has informed the Exchange about Transcript
AI summary

PCBL filed the transcript of its Q4 FY25 earnings conference call held on 29 April 2025, covering the quarter and year ended 31 March 2025.

Management said FY25 was its best ever operational year, with record EBITDA, Carbon Black sales, Specialty Black sales and power sales volume, and revenue crossing Rs 1 billion (USD) per the call.

Q4 FY25 consolidated revenue from operations rose 8.2% year-on-year to Rs 2,087 crore, with EBITDA down about 4.5% to Rs 317 crore and PAT of Rs 100 crore.

FY25 consolidated revenue rose 30.9% to Rs 8,404 crore and EBITDA rose 28.8% to Rs 1,384 crore; management expects a substantial improvement in Aquapharm's performance in FY26.

Management outlined capacity plans, including a 90,000 MT Chennai expansion, a new 6th plant on 116 acres at Naidupeta, Andhra Pradesh, and a target of over 1 million tonnes Carbon Black capacity by FY28.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Apr 2025presentation
Capex, Results
PCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical filed its Investor Update for Q4 FY25 (quarter ended March 2025) with the exchanges on 29 April 2025.

The update describes PCBL as India's largest and world's 7th largest carbon black producer, with 790 KTPA capacity across 5 locations, and as a top-3 global phosphonate producer.

It gives a Q4 FY25 revenue figure of Rs. 8,404 Crs for PCBL Chemical and Rs. 1,431 Crs for Aquapharm Chemicals, with volume figures of 5,96,262 MT and 95,806 MT.

The update includes a plan to commission a nano-silicon battery material pilot plant in Palej, Gujarat in 2025.

It also states plans to target roughly 50% conductive furnace black capacity addition over the next 5 years and to double R&D over the same period.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Apr 2025board outcome
Legal, Results
PCBL Chemical Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2025.
AI summary

Board of PCBL Chemical Limited approved the audited standalone and consolidated financial results for the quarter and year ended 31 March 2025, filed on 29 April 2025 with unmodified auditor opinion (statutory auditor SR Batliboi & Co. LLP).

Board approved appointment of Anjan Kumar Roy & Co. (Company Secretaries) as Secretarial Auditor for a first term of five consecutive years, FY 2025-26 to 2029-30, subject to member approval at the forthcoming AGM.

Board approved an updated Insider Trading Prohibition Code under SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2015.

The board meeting commenced at 12 noon and concluded at 1:55 p.m.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Mar 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited (erstwhile PCBL Limited) filed a credit rating intimation dated 17 March 2025 for its bank facilities.

ICRA Limited reviewed and reaffirmed the long-term ratings at [ICRA] AA with Stable outlook.

Rated facilities total Rs. 1,200.00 crores: Fund Based Working Capital Term Loan Rs. 480.00 crores, Fund Based Term Loan Rs. 712.00 crores, and Unallocated Rs. 8.00 crores.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Mar 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating disclosure dated 17 March 2025 for its commercial paper.

ICRA Limited reviewed the ratings and reaffirmed the commercial paper rating at [ICRA]A1+.

The instrument amount rated is Rs. 500.00 crores (total Rs. 500.00 crores).

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Mar 2025credit rating
Rating
PCBL Chemical Limited has informed the Exchange about Credit Rating
AI summary

PCBL Chemical Limited filed a credit rating intimation dated 17 March 2025 for its Non-Convertible Debentures.

ICRA Limited reviewed and reaffirmed the rating on NCDs of Rs. 700.00 crore at [ICRA]AA(Stable).

The total rated amount is Rs. 700.00 crore.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
03 Mar 2025presentationPCBL Chemical Limited has informed the Exchange about Investor Presentation
AI summary

PCBL Chemical Limited filed an investor presentation with NSE and BSE on 3 March 2025.

The presentation describes PCBL as India's largest and world's 7th largest carbon black producer, with capacity of 790 KTPA across 5 locations.

It states about 23% of revenue comes from Specialty Chemicals, with 9 manufacturing facilities, 350+ grades and presence in 60+ countries.

It notes green power generation capacity of 122 MW and annual R&D expenditure of Rs. 80+ Crs.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Feb 2025results
Results
Integrated Filing of
AI summary

PCBL Chemical Limited filed its integrated filing with unaudited standalone financial results for the quarter and nine months ended 31 December 2024, with an auditor's review report from S.R. Batliboi & Co. LLP dated 10 January 2025.

Standalone revenue from operations for Q3 FY25 was Rs 1,430.02 crore, against Rs 1,485.28 crore a year earlier; nine-month revenue was Rs 4,457.13 crore against Rs 4,180.87 crore.

Standalone net profit after tax for Q3 FY25 was Rs 110.99 crore, against Rs 144.45 crore a year earlier; nine-month profit after tax was Rs 356.31 crore against Rs 394.88 crore.

Standalone finance costs for Q3 FY25 were Rs 67.46 crore, against Rs 22.38 crore a year earlier.

Basic EPS for Q3 FY25 was Rs 2.94 (not annualised), against Rs 3.83 a year earlier. No deviation in use of issue proceeds and no loan default were reported.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
17 Jan 2025transcript
Capex, Dividend / buy-back, Guidance, Results
PCBL LIMITED has informed the Exchange about Transcript
AI summary

PCBL Chemical filed the transcript of its Q3 FY25 results conference call held on 10 January 2025 (for quarter and nine months ended 31 December 2024).

Management (CFO Raj Gupta) said consolidated revenue from operations rose 21% YoY to INR 2,010 crores in Q3, EBITDA rose about 15% to INR 328 crores, PAT was INR 93 crores; 9MFY25 revenue was INR 6,317 crores, up over 40% YoY.

Management said Carbon Black realisation fell mainly due to crude price movement (down about $6 QoQ) and product mix change; Aquapharm Q3 revenue was INR 328 crores with operational EBITDA of INR 51 crores.

Management said the 38,000 MTPA Aquapharm expansion is on track for commissioning by March 2025, and the Andhra Pradesh greenfield site can house about 400,000-450,000 MTPA, with a first phase of 150,000 MTPA costing roughly INR 950-960 crores.

Board declared an interim dividend of INR 5.50 per equity share (550%) of face value INR 1 for FY25.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2025dividend
Dividend / buy-back, Results
PCBL LIMITED has informed the Exchange that Board of Directors at its meeting held on January 10, 2025, declared Interim Dividend of Rs. 5.50 per equity share.
AI summary

PCBL Chemical Limited filed the outcome of its board meeting held on 10 January 2025, which approved unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024.

Standalone revenue from operations for the quarter ended 31.12.2024 was Rs 1,430.02 crores; profit after tax was Rs 110.99 crores; nine-month standalone profit after tax was Rs 356.31 crores.

The board declared an interim dividend of 550%, i.e. Rs 5.50 per equity share of Re 1 each, for FY 2024-25.

The record date for the interim dividend is Thursday, 16 January 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2025dividend
Dividend / buy-back, Results
PCBL LIMITED has informed the Exchange that Board of Directors at its meeting held on January 10, 2025, declared Interim Dividend of 5.50 per equity share.
AI summary

Outcome of the Board Meeting held on 10 January 2025: approved unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024, with limited review reports from the statutory auditors.

Standalone revenue from operations for the quarter ended 31.12.2024 was Rs 1,430.02 crores; standalone profit after tax was Rs 110.99 crores; nine-month standalone profit after tax was Rs 356.31 crores (Rs crores unless stated).

Board declared an interim dividend of 550%, i.e. Rs 5.50 per equity share of Re 1 each, for FY ending 31 March 2025, with Thursday, 16 January 2025 fixed as the record date.

Board meeting commenced at 3:00 PM and concluded at 4:10 PM.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Jan 2025results
Dividend / buy-back, Results
PCBL LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2024.
AI summary

PCBL Chemical Limited filed the outcome of its board meeting held on 10 January 2025, approving unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024.

Standalone revenue from operations for Q3 FY25 was Rs 1,430.02 crore, and standalone profit after tax was Rs 110.99 crore; for nine months ended 31 December 2024, revenue from operations was Rs 4,457.13 crore and profit after tax was Rs 356.31 crore.

The board declared an interim dividend of Rs 5.50 per equity share of Re 1 each (550%) for FY 2024-25, with 16 January 2025 fixed as the record date.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy

The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in